Stéphanie Colloud

Stéphanie Colloud joined Oxford Biomedica as the Site Head of France Operations in January 2024.   Stéphanie has over 20 years of experience in the life sciences and biologics CDMO industry, specialising in process and analytical development and CMC strategy. Previously, Stéphanie served as the Director of the Lyon site and as an Executive Committee Member of ABL Europe. In these roles, she successfully led the production, quality, and technical services departments, focusing on shaping innovative development strategies, establishing an AAV platform and launching the company’s presence in the cell and gene therapy field. Prior to this, she held the position of Chief Executive Officer at Accinov and also various operational roles at PX’Therapeutics. Stéphanie graduated in Cell Biology Engineering from the Joseph Fourier University of Grenoble, France, and holds a Master’s Degree in Quality Management in the Biotech & Biopharma Industry from the Faculty of Pharmacy of Angers, France.